Efficacy of Methods to Treat Multiple Gingival Recession Defects

University of Southern California

Status: Withdrawn

Conditions: Gingival Recession

Treatments: Device: Leukocyte-Platelet Rich Fibrin (L-PRF); Procedure: Intrasulcular Tunneling; Biological: Vestibular Incision Subperiosteal Tunnel Access (VISTA); Procedure: Coronally Advanced Flap

Study type: Interventional

Funder types: Other

Identifiers

NCT03124329

HS-16-00661

Details and patient eligibility

About

Rationale: Treatment of gingival recession defects requires coronal advancement of the gingival margin due to patient esthetic demand, tooth sensitivity and improvement of tooth prognosis, which can be accomplished either through a flap procedure or through a tunnel. It will be desirable to determine the efficacy of Vestibular Incision Subperiosteal Tunnel Access (VISTA) to Coronally Advanced Flap (CAF) procedure and intrasulcular tunneling.

Another aspect of the study is to determine whether autologous concentrate of platelets and leukocytes (leukocyte-platelet-rich fibrin; L-PRF) has equivalent efficacy to connective tissue autologous graft harvested from the palate.

The overall objective of this study is to evaluate the effectiveness of therapeutic modalities for the treatment of multiple gingival recession defects.

The study is designed as a prospective, randomized controlled clinical trial. Four groups will be compared:

Group 1: Coronally Advanced Flap (CAF) Group 2: VISTA Group 3: Intrasulcular tunneling (IST) Group 4: VISTA + L-PRF

Each of the groups will be treated without any graft material in order to examine the efficacy of coronal advancement and periodontal root coverage without the confounding variable of graft material. These techniques don't require any additional graft if there is adequate amount of keratinized gingiva

The study population will be patients who present to Advanced Graduate Program in Periodontology at the University of Southern California, USA, and are deemed to require treatment of multiple gingival recession defects. A total sample of 100 participants (23 participants per group) will provide a two sided test of means with 80% power at alpha of 0.05. The calculation was carried out using PASS Version 12 (Hintze, J. (2014). NCSS, LLC. Kaysville, Utah.)

The study duration will be 1 year. Follow-up visits after the surgery will occur after 3 days , 7 days and at weeks 3, 6, 12, 24, 36 and 52. These follow up visits consistent with standard of care follow up for gingival recession treatment and there will be no additional costs to the participant.

The Primary Outcome variable is complete root coverage; the Secondary Outcome Variables are clinical attachment level (CAL) gain, changes in gingival thickness and volume and the Tertiary Outcomes are aesthetic outcomes, postoperative pain and Patient satisfaction survey

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female individuals between ages of 18 to 70 years old
• Multiple contiguous gingival recession defects on a minimum of two adjacent teeth, exhibiting 3mm or more recession on at least one of those teeth
• No prior surgical treatment in the sites planned for therapy
• Minimum of 2 mm of keratinized gingiva
• Absence of cervical restorations extending to the CEJ
• Miller class 1, 2 and 3 recession defects will be included
• Availability to undergo treatment and return for follow up visits at specified post-operative intervals

Exclusion criteria

• Molar teeth
• Milller Class 4 recession defects
• Pregnancy (Self-reported)
• Smoking
• Uncontrolled local or systemic diseases that affects wound healing (diabetes, autoimmune or inflammatory disorders)
• Past history of systemic steroid use over 2 weeks within the last 2 years
• Poor oral hygiene on a non-compliant individual
• Ibuprofen Allergy/interlerance
• Anticoagulant therapy (e.g. Warfarin, Plavix, etc.), will not be automatic exclusion but patients will be required to have INR test performed and have values between 2.0 to 3. Physician consultation will be requested to determine whether anticoagulant therapy can be discontinued for 3 days prior to surgery.
• Objection to blood draw or application of blood products
• Students and staff from USC Ostrow school of Dentistry will not be recruited for this study

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

0 participants in 4 patient groups

Coronally Advanced Flap

Experimental group

Treatment:

Procedure: Coronally Advanced Flap

Vestibular Incision Subperiosteal Tunnel Access (VISTA)

Experimental group

Treatment:

Biological: Vestibular Incision Subperiosteal Tunnel Access (VISTA)

Intrasulcular tunneling

Experimental group

Treatment:

Procedure: Intrasulcular Tunneling

VISTA + Leukocyte-Platelet Rich Fibrin

Experimental group

Treatment:

Biological: Vestibular Incision Subperiosteal Tunnel Access (VISTA)

Device: Leukocyte-Platelet Rich Fibrin (L-PRF)